Yuki Noguchi

GLP-1 medications are sold under several different brand names and treat diabetes, obesity and sleep apnea. The drugs' effects on cancer are in very early stages of research. Michael Siluk/Universal Images Group via Getty Images hide caption toggle captio... See more

There is mounting evidence to suggest GLP-1 obesity treatments also help reduce cancer risk, according to several recent studies. The studies are correlative, but appear to show the drugs not only reverse the carcinogenic risks that come with obesity, the... See more

AILSA CHANG, HOST: There's mounting evidence suggesting that GLP-1 drugs also help reduce cancer risk. NPR's Yuki Noguchi reports that several recent studies find a strong correlation, but now the question is - why? YUKI NOGUCHI, BYLINE: GLP-1 drugs act o... See more

There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk. Copyright 2026 NPR There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce c... See more

AYESHA RASCOE, HOST: At last week's meeting of top cancer researchers, there was big news. It's a new drug that researchers say is redefining treatment of pancreatic cancer, a disease once thought to be virtually untreatable. We're joined now by NPR consu... See more